StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$256.35−5.86 (-2.23%)

Close on Nov 17, 2026Market cap $28.20BP/E 25.6Yield –

Quest Diagnostics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Quest Diagnostics's operating cash flow for the twelve months ending Sep 30, 2026 was $1.95B, up 3.5% year over year. For fiscal 2025 it was $1.89B, up 41.4% from the year before. Over ten years it grew 8.7% a year on average. The highest annual figure on record is $2.23B in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.89B+41.4%
FY2024Dec 31, 2024$1.33B+4.9%
FY2023Dec 31, 2023$1.27B-26.0%
FY2022Dec 31, 2022$1.72B-23.1%
FY2021Dec 31, 2021$2.23B+11.4%
FY2020Dec 31, 2020$2.01B+61.3%
FY2019Dec 31, 2019$1.24B+3.6%
FY2018Dec 31, 2018$1.20B+2.1%
FY2017Dec 31, 2017$1.18B+5.3%
FY2016Dec 31, 2016$1.12B+35.9%
FY2015Dec 31, 2015$821.00M-13.0%
FY2014Dec 31, 2014$944.00M+44.8%
FY2013Dec 31, 2013$652.00M-45.1%
FY2012Dec 31, 2012$1.19B+32.6%
FY2011Dec 31, 2011$895.00M-19.9%
FY2010Dec 31, 2010$1.12B+12.1%
FY2009Dec 31, 2009$997.42M-6.2%
FY2008Dec 31, 2008$1.06B+14.7%
FY2007Dec 31, 2007$926.92M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$611.00M+8.5%
Q2 FY2026Jun 30, 2026$597.00M+9.7%
Q1 FY2026Mar 31, 2026$278.00M-11.5%
Q4 FY2025Dec 31, 2025$465.00M+0.2%
Q3 FY2025Sep 30, 2025$563.00M+58.1%
Q2 FY2025Jun 30, 2025$544.00M+51.1%
Q1 FY2025Mar 31, 2025$314.00M+103.9%
Q4 FY2024Dec 31, 2024$464.00M-12.0%
Q3 FY2024Sep 30, 2024$356.00M+72.0%
Q2 FY2024Jun 30, 2024$360.00M-18.9%
Q1 FY2024Mar 31, 2024$154.00M+63.8%
Q4 FY2023Dec 31, 2023$527.00M+57.8%
Q3 FY2023Sep 30, 2023$207.00M-58.8%
Q2 FY2023Jun 30, 2023$444.00M+10.4%
Q1 FY2023Mar 31, 2023$94.00M-80.4%
Q4 FY2022Dec 31, 2022$334.00M-30.6%
Q3 FY2022Sep 30, 2022$502.00M-10.5%
Q2 FY2022Jun 30, 2022$402.00M-12.6%
Q1 FY2022Mar 31, 2022$480.00M-34.3%
Q4 FY2021Dec 31, 2021$481.00M-11.1%
Q3 FY2021Sep 30, 2021$561.00M-34.9%
Q2 FY2021Jun 30, 2021$460.00M+29.6%
Q1 FY2021Mar 31, 2021$731.00M+196.0%
Q4 FY2020Dec 31, 2020$541.00M+55.5%
Q3 FY2020Sep 30, 2020$862.00M+188.3%
Q2 FY2020Jun 30, 2020$355.00M+10.6%
Q1 FY2020Mar 31, 2020$247.00M-10.2%
Q4 FY2019Dec 31, 2019$348.00M+18.0%
Q3 FY2019Sep 30, 2019$299.00M-25.6%
Q2 FY2019Jun 30, 2019$321.00M-0.6%
Q1 FY2019Mar 31, 2019$275.00M+52.8%
Q4 FY2018Dec 31, 2018$295.00M-8.7%
Q3 FY2018Sep 30, 2018$402.00M+11.0%
Q2 FY2018Jun 30, 2018$323.00M+9.9%
Q1 FY2018Mar 31, 2018$180.00M-8.2%
Q4 FY2017Dec 31, 2017$323.00M-8.0%
Q3 FY2017Sep 30, 2017$362.00M–
Q2 FY2017Jun 30, 2017$294.00M–
Q1 FY2017Mar 31, 2017$196.00M–
Q4 FY2016Dec 31, 2016$351.00M–

More Quest Diagnostics figures

See a number that looks wrong?